About

Our goal is simple. We're on a mission to disrupt the status quo and innovating sample preparation.

Company Highlights

We're just getting started.

World's first commercial EME instrument
2024
ETN will launch the world's first commercial EME instrument, ETN-12 EME at Analytica 2024
First commercial prototype
2022
First commercial prototype was premiered at Analytica in Q2 2022.
5,3 million grant
2019
GTS/ETN receives a NOK 5,3 million grant from the Norwegian Research Council
Patent granted
2019
ETN’s first patent granted
Patent application
2017
ETN’s first patent application
Patent granted
2015
GTS first patent granted
ETN AS founded
2013
ETN AS was founded with start-up help from Innovation Norway
Base patent granted
2013
Stig Pedersen-Bjergaard and Knut Rasmussen’ base patent granted
Patent application
2011
GTS first patent application
Working full time
2010
Trond Løvli started working full time in the project
The first meeting
2009
The first meeting at the parking lot at UIO with Stig

Meet the team

Management

Daniel Kumar
Daniel Kumar
Chief Executive Officer
Trond Løvli
Trond Løvli
Head of Development

Board of Directors

Roger Trones
Roger Trones
Chairman
Jon Ola Frankplads
Jon Ola Frankplads
Board member
Trond Løvli
Trond Løvli
Board member
Dimitrios Mantzilas
Dimitrios Mantzilas
Board member

Scientific Advisory board

Elisabeth Leere Øiestad
Elisabeth Leere Øiestad
Associate Professor II, Department of Pharmacy - UiO
Herald Reiersen
Herald Reiersen
Head of Research and Innovation, Helgeland Hospital
Stig Pedersen-Bjergaard
Stig Pedersen-Bjergaard
Professor, Department of Pharmacy - UiO
Ørjan Grøttem Martinsen
Ørjan Grøttem Martinsen
Professor, Department of Physics - UiO
Asgeir Husa
Asgeir Husa
Senior Analytical Advisor

Extraction Technologies Japan

Atsushi Tsunomura
Atsushi Tsunomura
Bachelor of Engineering (Medical Electronics) from Tamagawa University
Kazuyuki Takama
Kazuyuki Takama
Master of Biotechnology from Flinders University (Australia)